Description
— Opti-Gen Peptides
CJC-1295 no DAC 5mg/ IPA Blend 5mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide blend supplied as a 10 mg total sealed vial for lawful laboratory research in the UK. CJC component: no DAC. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Identification
| Product name | CJC-1295 / IPA Blend |
| CJC form | No DAC (modified GRF 1–29) |
| Supplier | Opti-Gen Peptides |
| Contents | 10 mg total per vial (ratio on lot COA) |
| Component A | CJC-1295 no DAC / mod GRF 1–29 (CAS often cited 447338-55-6) |
| Component B | Ipamorelin — Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (CAS 170851-70-4) |
| Intended use | Laboratory / in-vitro research only |
Not CJC-1295 with DAC. Not sermorelin, tesamorelin, GHRP-2 or GHRP-6.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.
Published research context (not product claims)
Modified GRF(1–29) / CJC-1295 no DAC is a GHRH-receptor research ligand. It is not the same molecule as CJC-1295 with DAC. ConjuChem / Teichman-type DAC papers must not be applied to this lot.
Ipamorelin is a GHS-R1a (ghrelin receptor) pentapeptide from the Raun / Novo Nordisk secretagogue series. Receptor papers describe selective GHS-R assays. They are not growth-hormone product claims.
Shop marketing that pairs the two as a “GH secretagogue stack” is not a claim for this listing. GHRH analogues and GHRPs may be WADA-restricted. There is no UK marketing authorisation.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.